Trial Profile

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients.

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Doripenem (Primary)
Indications Bacterial infections
Focus Pharmacokinetics
Acronyms Dori-MD-ICU

Most Recent Events

18 Jun 2021 This trial has been completed in Austria, according to European Clinical Trials Database.
18 Oct 2014 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
18 Oct 2014 Planned number of patients changed from 16 to 20, according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com